{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:26:33Z","timestamp":1793039193772,"version":"4.5.0"},"reference-count":164,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1054,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13311-020-00938-y","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T15:02:29Z","timestamp":1602082949000},"page":"1480-1494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Sleep Issues in Parkinson's Disease and Their Management"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-5275","authenticated-orcid":false,"given":"Jos\u00e9 Rafael P.","family":"Zuzu\u00e1rregui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel H.","family":"During","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-020-00938-y_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mds.23462","article-title":"The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease","volume":"26","author":"Martinez-Martin","year":"2011","journal-title":"Mov Disord."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00415-010-5786-y","article-title":"Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease","volume":"258","author":"G\u00f3mez-Esteban","year":"2011","journal-title":"J Neurol."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ageing\/afj087","article-title":"Sleep-related problems of Parkinson's disease","volume":"35","author":"Dhawan","year":"2006","journal-title":"Age Ageing."},{"key":"10.1007\/s13311-020-00938-y_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.parkreldis.2019.04.014","article-title":"Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's","volume":"64","author":"Hurt","year":"2019","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1007\/s13311-020-00938-y_bib5","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2147\/NDT.S213917","article-title":"Impact of non-motor symptoms in Parkinson's disease: a PMDAlliance survey","volume":"15","author":"Hermanowicz","year":"2019","journal-title":"Neuropsychiatr Dis Treat."},{"key":"10.1007\/s13311-020-00938-y_bib6","doi-asserted-by":"crossref","unstructured":"Mantovani S, Smith SS, Gordon R, O'Sullivan JD. An overview of sleep and circadian dysfunction in Parkinson's disease. J Sleep Res. 2018;27(3):e12673.","DOI":"10.1111\/jsr.12673"},{"issue":"5","key":"10.1007\/s13311-020-00938-y_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mds.26918","article-title":"Management of sleep disorders in Parkinson's disease and multiple system atrophy","volume":"32","author":"Videnovic","year":"2017","journal-title":"Mov Disord."},{"issue":"5","key":"10.1007\/s13311-020-00938-y_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/jnnp-2013-306104","article-title":"REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease","volume":"85","author":"Rolinski","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"Suppl 1","key":"10.1007\/s13311-020-00938-y_bib9","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1353-8020(13)70004-X","article-title":"Restless legs syndrome in Parkinson's disease","volume":"20","author":"Rijsman","year":"2014","journal-title":"Parkinsonism Relat Disord."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40675-017-0079-y","article-title":"Sleep and Circadian Rhythm Disorders in Parkinson's Disease","volume":"3","author":"Gros","year":"2017","journal-title":"Curr Sleep Med Rep."},{"key":"10.1007\/s13311-020-00938-y_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.parkreldis.2016.09.010","article-title":"The course of insomnia in Parkinson's disease","volume":"33","author":"Zhu","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"10.1007\/s13311-020-00938-y_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp.73.6.629","article-title":"The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease","volume":"73","author":"Chaudhuri","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mds.23476","article-title":"Parkinson's disease sleep scale\u2013validation of the revised version PDSS-2","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.parkreldis.2011.08.013","article-title":"Validation of the non-motor symptoms questionnaire (NMS-Quest)","volume":"18","author":"Romenets","year":"2012","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1007\/s13311-020-00938-y_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.sleep.2016.06.026","article-title":"Clinically relevant cut-off values for the Parkinson's Disease Sleep Scale-2 (PDSS-2): a validation study","volume":"24","author":"Muntean","year":"2016","journal-title":"Sleep Med."},{"issue":"7","key":"10.1007\/s13311-020-00938-y_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.sleep.2013.03.010","article-title":"Subjectively impaired bed mobility in Parkinson disease affects sleep efficiency","volume":"14","author":"Louter","year":"2013","journal-title":"Sleep Med."},{"issue":"11","key":"10.1007\/s13311-020-00938-y_bib17","doi-asserted-by":"crossref","first-page":"e0187616","DOI":"10.1371\/journal.pone.0187616","article-title":"Impact of inability to turn in bed assessed by a wearable three-axis accelerometer on patients with Parkinson's disease","volume":"12","author":"Uchino","year":"2017","journal-title":"PLoS One."},{"key":"10.1007\/s13311-020-00938-y_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fneur.2017.00042","article-title":"The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice","volume":"8","author":"Loddo","year":"2017","journal-title":"Front Neurol."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib19","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1468-1331.2010.03213.x","article-title":"Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease","volume":"18","author":"Wailke","year":"2011","journal-title":"Eur J Neurol."},{"key":"10.1007\/s13311-020-00938-y_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.sleep.2016.01.016","article-title":"Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study","volume":"21","author":"Pierantozzi","year":"2016","journal-title":"Sleep Med."},{"key":"10.1007\/s13311-020-00938-y_bib21","first-page":"3724148","article-title":"Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording","volume":"2016","author":"Calandra-Buonaura","year":"2016","journal-title":"Parkinsons Dis."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1468-1331.2011.03442.x","article-title":"Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease","volume":"19","author":"Ray Chaudhuri","year":"2012","journal-title":"Eur J Neurol."},{"issue":"6","key":"10.1007\/s13311-020-00938-y_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1007\/s13311-020-00938-y_bib24","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2147\/DDDT.S160300","article-title":"Comparison of nocturnal symptoms in advanced Parkinson's disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations","volume":"12","author":"Xiang","year":"2018","journal-title":"Drug Des Devel Ther."},{"key":"10.1007\/s13311-020-00938-y_bib25","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.2147\/NDT.S116476","article-title":"Rasagiline for sleep disorders in patients with Parkinson's disease: a prospective observational study","volume":"12","author":"Schettino","year":"2016","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"22","key":"10.1007\/s13311-020-00938-y_bib26","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1056\/NEJMoa0907083","article-title":"Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease","volume":"362","author":"Follett","year":"2010","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.2008.929","article-title":"Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial","volume":"301","author":"Weaver","year":"2009","journal-title":"JAMA."},{"issue":"7","key":"10.1007\/s13311-020-00938-y_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1205158","article-title":"Neurostimulation for Parkinson's disease with early motor complications","volume":"368","author":"Schuepbach","year":"2013","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1007\/s13311-020-00938-y_bib29","doi-asserted-by":"crossref","first-page":"e9750","DOI":"10.1097\/MD.0000000000009750","article-title":"Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study","volume":"97","author":"Kurcova","year":"2018","journal-title":"Medicine (Baltimore)."},{"issue":"8","key":"10.1007\/s13311-020-00938-y_bib30","doi-asserted-by":"crossref","first-page":"e0221219","DOI":"10.1371\/journal.pone.0221219","article-title":"Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease","volume":"14","author":"Choi","year":"2019","journal-title":"PLoS One."},{"issue":"2","key":"10.1007\/s13311-020-00938-y_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JPD-150540","article-title":"Bilateral Subthalamic Stimulation can Improve Sleep Quality in Parkinson's Disease","volume":"5","author":"Deli","year":"2015","journal-title":"J Parkinsons Dis."},{"key":"10.1007\/s13311-020-00938-y_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fneur.2018.00697","article-title":"Deep Brain Stimulation and Sleep-Wake Disturbances in Parkinson Disease: A Review","volume":"9","author":"Sharma","year":"2018","journal-title":"Front Neurol."},{"issue":"5","key":"10.1007\/s13311-020-00938-y_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/nau.22764","article-title":"A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders","volume":"35","author":"Sakakibara","year":"2016","journal-title":"Neurourol Urodyn."},{"issue":"3-4","key":"10.1007\/s13311-020-00938-y_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000495797","article-title":"Autonomic Symptoms Correlate with Non-Autonomic Non-Motor Symptoms and Sleep Problems in Patients with Parkinson's Disease","volume":"80","author":"Matsubara","year":"2018","journal-title":"Eur Neurol."},{"issue":"5","key":"10.1007\/s13311-020-00938-y_bib35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Parkinsonism Relat Disord."},{"issue":"7","key":"10.1007\/s13311-020-00938-y_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40266-015-0281-x","article-title":"Managing Urinary Incontinence in Patients with Dementia: Pharmacological Treatment Options and Considerations","volume":"32","author":"Orme","year":"2015","journal-title":"Drugs Aging."},{"key":"10.1007\/s13311-020-00938-y_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2018.07.005","article-title":"Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort","volume":"57","author":"Peyronnet","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"issue":"Suppl 1","key":"10.1007\/s13311-020-00938-y_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson's disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur J Neurol."},{"key":"10.1007\/s13311-020-00938-y_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-444-64012-3.00007-1","article-title":"Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics","volume":"165","author":"Butala","year":"2019","journal-title":"Handb Clin Neurol."},{"issue":"8","key":"10.1007\/s13311-020-00938-y_bib40","first-page":"696","article-title":"Decreased sleep quality in Parkinson's patients is associated with higher anxiety and depression prevalence and severity, and correlates with pain intensity and quality","volume":"40","author":"Rana","year":"2018","journal-title":"Neurol Res."},{"key":"10.1007\/s13311-020-00938-y_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2017.01.015","article-title":"The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-na\u00efve Parkinson's disease","volume":"39","author":"Rutten","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1007\/s13311-020-00938-y_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jocn.2019.08.058","article-title":"Potential predictors of quality of life in Parkinson's Disease: Sleep and mood disorders","volume":"70","author":"Palmeri","year":"2019","journal-title":"J Clin Neurosci."},{"issue":"6","key":"10.1007\/s13311-020-00938-y_bib43","doi-asserted-by":"crossref","first-page":"e00967","DOI":"10.1002\/brb3.967","article-title":"Sleep disturbances and depression severity in patients with Parkinson's disease","volume":"8","author":"Kay","year":"2018","journal-title":"Brain Behav."},{"issue":"7","key":"10.1007\/s13311-020-00938-y_bib44","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","article-title":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease \u2013 a randomized study","volume":"19","author":"Rios Romenets","year":"2013","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1007\/s13311-020-00938-y_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40734-017-0062-2","article-title":"A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease (ACCORD-PD)","volume":"4","author":"Patel","year":"2017","journal-title":"J Clin Mov Disord."},{"key":"10.1007\/s13311-020-00938-y_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41531-017-0027-z","article-title":"Cognitive behavioral therapy for insomnia in Parkinson's disease: a case series","volume":"3","author":"Humbert","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1007\/s13311-020-00938-y_bib47","doi-asserted-by":"crossref","unstructured":"Lebrun C, G\u00e9ly-Nargeot MC, Rossignol A, Geny C, Bayard S. Efficacy of cognitive behavioral therapy for insomnia comorbid to Parkinson's disease: A focus on psychological and daytime functioning with a single-case design with multiple baselines. J Clin Psychol. 2019 20.","DOI":"10.1016\/j.sleep.2019.11.599"},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s13760-019-01214-3","article-title":"Bright light therapy with a head-mounted device for anxiety, depression, sleepiness and fatigue in patients with Parkinson's disease","volume":"119","author":"Raymackers","year":"2019","journal-title":"Acta Neurol Belg."},{"issue":"8","key":"10.1007\/s13311-020-00938-y_bib49","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1519\/JSC.0000000000001685","article-title":"Resistance Training Improves Sleep Quality in Subjects With Moderate Parkinson's Disease","volume":"31","author":"Silva-Batista","year":"2017","journal-title":"J Strength Cond Res."},{"issue":"6","key":"10.1007\/s13311-020-00938-y_bib50","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mds.28009","article-title":"Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease","volume":"35","author":"Amara","year":"2020","journal-title":"Mov Disord."},{"issue":"2","key":"10.1007\/s13311-020-00938-y_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov Disord."},{"issue":"6","key":"10.1007\/s13311-020-00938-y_bib52","first-page":"907","article-title":"Antidepressants Increase REM Sleep Muscle Tone in Patients with and without REM Sleep Behavior Disorder","volume":"38","author":"McCarter","year":"2015","journal-title":"Sleep."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10072-016-2744-1","article-title":"Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson's disease: a meta and meta-regression analysis","volume":"38","author":"Zhang","year":"2017","journal-title":"Neurol Sci."},{"key":"10.1007\/s13311-020-00938-y_bib54","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer's disease: case-control study","volume":"349","author":"de Gage Billioti","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cger.2014.04.007","article-title":"Sleep in older adults: normative changes, sleep disorders, and treatment options","volume":"30","author":"Gooneratne","year":"2014","journal-title":"Clin Geriatr Med."},{"issue":"11","key":"10.1007\/s13311-020-00938-y_bib56","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults","volume":"63","author":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1007\/s13311-020-00938-y_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med."},{"issue":"7","key":"10.1007\/s13311-020-00938-y_bib58","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jagp.2017.03.004","article-title":"Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials","volume":"25","author":"Herring","year":"2017","journal-title":"Am J Geriatr Psychiatry."},{"issue":"2","key":"10.1007\/s13311-020-00938-y_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/sleep\/9.2.293","article-title":"Chronic behavioral disorders of human REM sleep: a new category of parasomnia","volume":"9","author":"Schenck","year":"1986","journal-title":"Sleep."},{"key":"10.1007\/s13311-020-00938-y_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.05115.x","article-title":"REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions","volume":"1184","author":"Boeve","year":"2010","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5665\/sleep.5332","article-title":"The Clinical Phenotype of Idiopathic Rapid Eye Movement Sleep Behavior Disorder at Presentation: A Study in 203 Consecutive Patients","volume":"39","author":"Fern\u00e1ndez-Arcos","year":"2016","journal-title":"Sleep."},{"issue":"1 Sleep Disorders","key":"10.1007\/s13311-020-00938-y_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1212\/01.CON.0000427215.07715.73","article-title":"The neurobiology of sleep","volume":"19","author":"Saper","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-018-2852-8","article-title":"The REM sleep circuit and how its impairment leads to REM sleep behavior disorder","volume":"373","author":"Iranzo","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib64","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.sleep.2006.08.017","article-title":"Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease","volume":"8","author":"Boeve","year":"2007","journal-title":"Sleep Med."},{"issue":"10","key":"10.1007\/s13311-020-00938-y_bib65","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/mds.26347","article-title":"REM sleep behavior disorder and neuropathology in Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","article-title":"Idiopathic REM sleep behaviour disorder and neurodegeneration - an update","volume":"14","author":"H\u00f6gl","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"10.1007\/s13311-020-00938-y_bib67","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.smrv.2016.11.002","article-title":"Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk?","volume":"36","author":"Arnaldi","year":"2017","journal-title":"Sleep Med Rev"},{"issue":"2","key":"10.1007\/s13311-020-00938-y_bib68","doi-asserted-by":"crossref","first-page":"e89741","DOI":"10.1371\/journal.pone.0089741","article-title":"Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients","volume":"9","author":"Iranzo","year":"2014","journal-title":"PLoS One."},{"key":"10.1007\/s13311-020-00938-y_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","article-title":"The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies","volume":"43","author":"Galbiati","year":"2019","journal-title":"Sleep Med Rev."},{"issue":"11","key":"10.1007\/s13311-020-00938-y_bib70","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11940-016-0433-2","article-title":"St Louis EK Treatment of REM Sleep Behavior Disorder","volume":"18","author":"Jung","year":"2016","journal-title":"Curr Treat Options Neurol."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5664\/jcsm.27717","article-title":"Best Practice Guide for the Treatment of REM Sleep Behavior Disorder (RBD)","volume":"6","author":"Aurora","year":"2010","journal-title":"J Clin Sleep Med."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib72","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.sleep.2007.11.019","article-title":"Idiopathic rapid-eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset","volume":"10","author":"Teman","year":"2009","journal-title":"Sleep Med."},{"key":"10.1007\/s13311-020-00938-y_bib73","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sleep.2017.05.012","article-title":"The influence of sleep disordered breathing in REM sleep behavior disorder","volume":"37","author":"Bugalho","year":"2017","journal-title":"Sleep Med."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib74","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s11325-017-1563-9","article-title":"Prevalence of obstructive sleep apnoea in REM behaviour disorder: response to continuous positive airway pressure therapy","volume":"22","author":"Gabryelska","year":"2018","journal-title":"Sleep Breath."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.sleep.2012.09.009","article-title":"An observational clinical and video-polysomnographic study of the effects of clonazepam in REM sleep behavior disorder","volume":"14","author":"Ferri","year":"2013","journal-title":"Sleep Med."},{"key":"10.1007\/s13311-020-00938-y_bib76","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.sleep.2015.12.020","article-title":"A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder","volume":"21","author":"Li","year":"2016","journal-title":"Sleep Med."},{"key":"10.1007\/s13311-020-00938-y_bib77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2019.04.029","article-title":"Clonazepam for probable REM sleep behavior disorder in Parkinson's disease: A randomized placebo-controlled trial","volume":"401","author":"Shin","year":"2019","journal-title":"J Neurol Sci."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1389-9457(03)00072-8","article-title":"Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients","volume":"4","author":"Boeve","year":"2003","journal-title":"Sleep Med."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib79","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2869.2010.00848.x","article-title":"A two-part, double-blind, placebo-controlled trial of exogens melatonin in REM sleep behaviour disorder","volume":"19","author":"Kunz","year":"2010","journal-title":"J Sleep Res."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.sleep.2014.09.011","article-title":"Melatonin therapy for REM sleep behavior disorder: a critical review of evidence","volume":"16","author":"McGrane","year":"2015","journal-title":"Sleep Med."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib81","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/acn3.753","article-title":"Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder","volume":"6","author":"Jun","year":"2019","journal-title":"Ann Clin Transl Neurol."},{"key":"10.1007\/s13311-020-00938-y_bib82","doi-asserted-by":"crossref","unstructured":"Gilat M, Coeytaux Jackson A, Marshall NS, et al. Melatonin for Rapid Eye Movement Sleep Behavior Disorder in Parkinson's Disease: A Randomised Controlled Trial. Mov Disord. 2019 31.","DOI":"10.1002\/mds.27886"},{"issue":"18","key":"10.1007\/s13311-020-00938-y_bib83","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2169\/internalmedicine.52.9179","article-title":"Use of ramelteon for the treatment of secondary REM sleep behavior disorder","volume":"52","author":"Nomura","year":"2013","journal-title":"Intern Med."},{"issue":"5","key":"10.1007\/s13311-020-00938-y_bib84","doi-asserted-by":"crossref","first-page":"689","DOI":"10.5664\/jcsm.5796","article-title":"An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder","volume":"12","author":"Esaki","year":"2016","journal-title":"J Clin Sleep Med."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib85","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.22691","article-title":"Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease","volume":"71","author":"Kotagal","year":"2012","journal-title":"Ann Neurol."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib86","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/mds.24909","article-title":"Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease","volume":"27","author":"Di Giacopo","year":"2012","journal-title":"Mov Disord."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib87","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1567205011666140302195648","article-title":"Rivastigmine for refractory REM behavior disorder in mild cognitive impairment","volume":"11","author":"Brunetti","year":"2014","journal-title":"Curr Alzheimer Res."},{"issue":"6","key":"10.1007\/s13311-020-00938-y_bib88","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1212\/WNL.55.6.870","article-title":"Treatment of REM sleep behavior disorder with donepezil: a report of three cases","volume":"55","author":"Ringman","year":"2000","journal-title":"Neurology."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib89","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1041610203009621","article-title":"Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies","volume":"15","author":"Massironi","year":"2003","journal-title":"Int Psychogeriatr."},{"issue":"10","key":"10.1007\/s13311-020-00938-y_bib90","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/gps.2506","article-title":"The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia","volume":"25","author":"Larsson","year":"2010","journal-title":"Int J Geriatr Psychiatry."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1620\/tjem.226.177","article-title":"Effectiveness of pramipexole, a dopamine agonist, on rapid eye movement sleep behavior disorder","volume":"226","author":"Sasai","year":"2012","journal-title":"Tohoku J Exp Med."},{"issue":"10","key":"10.1007\/s13311-020-00938-y_bib92","first-page":"1418","article-title":"Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease","volume":"31","author":"Kumru","year":"2008","journal-title":"Sleep."},{"key":"10.1007\/s13311-020-00938-y_bib93","unstructured":"Abenza Abild\u00faa MJ, Miralles Martinez A, Arpa Guti\u00e9rrez FJ, et al. Conditions associated with REM sleep behaviour disorder: Description of a hospital series. Neurologia. 2017."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib94","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/WNF.0b013e318193e394","article-title":"Successful treatment of REM sleep behavior disorder with sodium oxybate","volume":"32","author":"Shneerson","year":"2009","journal-title":"Clin Neuropharmacol."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib95","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jamaneurol.2015.2904","article-title":"A Case of Rapid Eye Movement Sleep Behavior Disorder in Parkinson Disease Treated With Sodium Oxybate","volume":"73","author":"Liebenthal","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1007\/s13311-020-00938-y_bib96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.sleep.2016.04.014","article-title":"Sodium oxybate for idiopathic REM sleep behavior disorder: a report on two patients","volume":"32","author":"Moghadam","year":"2017","journal-title":"Sleep Med."},{"issue":"8","key":"10.1007\/s13311-020-00938-y_bib97","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria\u2013history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med."},{"issue":"14","key":"10.1007\/s13311-020-00938-y_bib98","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/WNL.0000000000002542","article-title":"Restless legs syndrome associated with major diseases: A systematic review and new concept","volume":"86","author":"Trenkwalder","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib99","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.parkreldis.2012.12.005","article-title":"Prevalence and profile of Restless Legs Syndrome in Parkinson's disease and other neurodegenerative disorders: a case-control study","volume":"19","author":"Bhalsing","year":"2013","journal-title":"Parkinsonism Relat Disord."},{"issue":"8","key":"10.1007\/s13311-020-00938-y_bib100","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.54.8.1698","article-title":"Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome","volume":"54","author":"Earley","year":"2000","journal-title":"Neurology."},{"key":"10.1007\/s13311-020-00938-y_bib101","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.slsci.2014.10.002","article-title":"Sleep disorders: a review of the interface between restless legs syndrome and iron metabolism","volume":"7","author":"Daubian-Nose","year":"2014","journal-title":"Sleep Sci"},{"key":"10.1007\/s13311-020-00938-y_bib102","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.mayocp.2013.06.016","article-title":"Medical Advisory Board of the Willis-Ekbom Disease Foundation. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome","volume":"88","author":"Silber","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1007\/s13311-020-00938-y_bib103","doi-asserted-by":"crossref","first-page":"e06","DOI":"10.4088\/JCP.12074nr2c","article-title":"Common comorbidities and differential diagnosis of restless legs syndrome","volume":"75","author":"Ondo","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1007\/s13311-020-00938-y_bib104","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5665\/sleep.3416","article-title":"Restless legs syndrome: an early clinical feature of Parkinson disease in men","volume":"37","author":"Wong","year":"2014","journal-title":"Sleep."},{"key":"10.1007\/s13311-020-00938-y_bib105","first-page":"40(2)","article-title":"Association of Restless Legs Syndrome With Incident Parkinson's Disease","volume":"1","author":"Szatmari","year":"2017","journal-title":"Sleep."},{"issue":"1-2","key":"10.1007\/s13311-020-00938-y_bib106","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jns.2011.08.012","article-title":"A study of the prevalence of restless legs syndrome in previously untreated Parkinson's disease patients: absence of co-morbid association","volume":"310","author":"Angelini","year":"2011","journal-title":"J Neurol Sci."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib107","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/mds.22410","article-title":"Factors contributing to the development of restless legs syndrome in patients with Parkinson disease","volume":"24","author":"Lee","year":"2009","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-020-00938-y_bib108","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.sleep.2017.11.1126","article-title":"Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome\/Willis-Ekbom disease in adults and children: an IRLSSG task force report","volume":"41","author":"Allen","year":"2018","journal-title":"Sleep Med."},{"key":"10.1007\/s13311-020-00938-y_bib109","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.sleep.2013.05.016","article-title":"The long-term treatment of restless legs syndrome\/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group","volume":"14","author":"Garcia-Borreguero","year":"2013","journal-title":"Sleep Med"},{"issue":"11","key":"10.1007\/s13311-020-00938-y_bib110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11940-019-0596-8","article-title":"Therapies for Restless Legs in Parkinson's Disease","volume":"21","author":"De Cock Cochen","year":"2019","journal-title":"Curr Treat Options Neurol"},{"issue":"24","key":"10.1007\/s13311-020-00938-y_bib111","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1212\/WNL.0000000000003388","article-title":"Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"87","author":"Winkelman","year":"2016","journal-title":"Neurology."},{"issue":"9","key":"10.1007\/s13311-020-00938-y_bib112","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.clinthera.2013.06.016","article-title":"Ropinirole in patients with restless legs syndrome and baseline IRLS total scores \u2265 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension","volume":"35","author":"Giorgi","year":"2013","journal-title":"Clin Ther."},{"key":"10.1007\/s13311-020-00938-y_bib113","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.sleep.2014.09.015","article-title":"Pramipexole for Chinese people with primary restless legs syndrome: a 12-week multicenter, randomized, double-blind study","volume":"16","author":"Zhang","year":"2015","journal-title":"Sleep Med"},{"key":"10.1007\/s13311-020-00938-y_bib114","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.sleep.2008.09.001","article-title":"Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial","volume":"9","author":"Ferini-Strambi","year":"2008","journal-title":"Sleep Med"},{"key":"10.1007\/s13311-020-00938-y_bib115","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/mds.23157","article-title":"Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States","volume":"25","author":"Hening","year":"2010","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-020-00938-y_bib116","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.sleep.2013.07.007","article-title":"Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study","volume":"14","author":"Inoue","year":"2013","journal-title":"Sleep Med"},{"key":"10.1007\/s13311-020-00938-y_bib117","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/sleep\/22.8.1073","article-title":"Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial","volume":"22","author":"Benes","year":"1999","journal-title":"Sleep"},{"key":"10.1007\/s13311-020-00938-y_bib118","doi-asserted-by":"crossref","unstructured":"Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M. Levodopa for restless legs syndrome. Cochrane Database Syst Rev. 2011;(2):CD005504.","DOI":"10.1002\/14651858.CD005504.pub2"},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib119","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jsmc.2015.05.020","article-title":"Dopaminergic Augmentation in Restless Legs Syndrome\/Willis-Ekbom Disease: Identification and Management","volume":"10","author":"Garc\u00eda-Borreguero","year":"2015","journal-title":"Sleep Med Clin."},{"issue":"8","key":"10.1007\/s13311-020-00938-y_bib120","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nrneurol.2015.122","article-title":"Restless legs syndrome-current therapies and management of augmentation","volume":"11","author":"Trenkwalder","year":"2015","journal-title":"Nat Rev Neurol."},{"issue":"11","key":"10.1007\/s13311-020-00938-y_bib121","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S1474-4422(18)30311-9","article-title":"Comorbidities, treatment, and pathophysiology in restless legs syndrome","volume":"17","author":"Trenkwalder","year":"2018","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1007\/s13311-020-00938-y_bib122","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/00325481.2017.1360747","article-title":"Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations","volume":"129","author":"Geyer","year":"2017","journal-title":"Postgrad Med."},{"key":"10.1007\/s13311-020-00938-y_bib123","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.sleep.2018.11.025","article-title":"Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment","volume":"55","author":"Garcia-Borreguero","year":"2019","journal-title":"Sleep Med."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib124","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1212\/WNL.0000000000002803","article-title":"Augmentation and impulsive behaviors in restless legs syndrome: Coexistence or association?","volume":"87","author":"Heim","year":"2016","journal-title":"Neurology."},{"key":"10.1007\/s13311-020-00938-y_bib125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fneur.2019.00351","article-title":"Impulse Control Disorders in Parkinson's Disease","volume":"10","author":"Gatto","year":"2019","journal-title":"A Brief and Comprehensive Review. Front Neurol."},{"issue":"7","key":"10.1007\/s13311-020-00938-y_bib126","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.27260","article-title":"Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)\u00a7","volume":"33","author":"Winkelmann","year":"2018","journal-title":"Mov Disord."},{"issue":"9","key":"10.1007\/s13311-020-00938-y_bib127","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/11634870-000000000-00000","article-title":"Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies","volume":"26","author":"VanMeter","year":"2012","journal-title":"CNS Drugs."},{"issue":"7","key":"10.1007\/s13311-020-00938-y_bib128","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1303646","article-title":"Comparison of pregabalin with pramipexole for restless legs syndrome","volume":"370","author":"Allen","year":"2014","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1007\/s13311-020-00938-y_bib129","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1474-4422(13)70239-4","article-title":"Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension","volume":"12","author":"Trenkwalder","year":"2013","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1007\/s13311-020-00938-y_bib130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.sleep.2014.11.020","article-title":"Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?","volume":"16","author":"Marques","year":"2015","journal-title":"Sleep Med."},{"issue":"11","key":"10.1007\/s13311-020-00938-y_bib131","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.1212\/WNL.0000000000006162","article-title":"Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease","volume":"91","author":"Klepitskaya","year":"2018","journal-title":"Neurology."},{"issue":"6","key":"10.1007\/s13311-020-00938-y_bib132","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10072-019-03785-8","article-title":"Excessive daytime sleepiness and its impact on quality of life in de novo Parkinson's disease","volume":"40","author":"Yoo","year":"2019","journal-title":"Neurol Sci."},{"issue":"8","key":"10.1007\/s13311-020-00938-y_bib133","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/jnnp-2016-315023","article-title":"Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease","volume":"88","author":"Amara","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"11","key":"10.1007\/s13311-020-00938-y_bib134","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/jnnp-2017-316136","article-title":"Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study","volume":"88","author":"Suzuki","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1007\/s13311-020-00938-y_bib135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.parkreldis.2016.01.020","article-title":"Course and risk factors for excessive daytime sleepiness in Parkinson's disease","volume":"24","author":"Zhu","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib136","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00415-018-09179-8","article-title":"Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease","volume":"266","author":"Liguori","year":"2019","journal-title":"J Neurol."},{"issue":"2","key":"10.1007\/s13311-020-00938-y_bib137","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/ane.12704","article-title":"Mood and neural correlates of excessive daytime sleepiness in Parkinson's disease","volume":"136","author":"Wen","year":"2017","journal-title":"Acta Neurol Scand."},{"issue":"10","key":"10.1007\/s13311-020-00938-y_bib138","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/mds.26248","article-title":"Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study","volume":"30","author":"Simuni","year":"2015","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-020-00938-y_bib139","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jns.2018.02.032","article-title":"Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease","volume":"387","author":"Yousaf","year":"2018","journal-title":"J Neurol Sci."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JPD-130184","article-title":"Daytime sleepiness is associated with falls in Parkinson's disease","volume":"3","author":"Spindler","year":"2013","journal-title":"J Parkinsons Dis."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib141","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamaneurol.2016.5192","article-title":"Timed Light Therapy for Sleep and Daytime Sleepiness Associated With Parkinson Disease: A Randomized Clinical Trial","volume":"74","author":"Videnovic","year":"2017","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1007\/s13311-020-00938-y_bib142","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.0b013e318263570d","article-title":"Caffeine for treatment of Parkinson disease: a randomized controlled trial","volume":"79","author":"Postuma","year":"2012","journal-title":"Neurology."},{"issue":"8","key":"10.1007\/s13311-020-00938-y_bib143","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/sleep\/25.8.62","article-title":"Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial","volume":"25","author":"H\u00f6gl","year":"2002","journal-title":"Sleep."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib144","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.10390","article-title":"Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease","volume":"18","author":"Adler","year":"2003","journal-title":"Mov Disord."},{"issue":"12","key":"10.1007\/s13311-020-00938-y_bib145","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/jnnp.2005.065870","article-title":"Modafinail for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial","volume":"76","author":"Ondo","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib146","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/jamaneurol.2017.3171","article-title":"Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial","volume":"75","author":"B\u00fcchele","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1007\/s13311-020-00938-y_bib147","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jns.2017.07.045","article-title":"Istradefylline improves daytime sleepiness in patients with Parkinson's disease: An open-label, 3-month study","volume":"380","author":"Suzuki","year":"2017","journal-title":"J Neurol Sci."},{"issue":"2","key":"10.1007\/s13311-020-00938-y_bib148","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11910-996-0041-8","article-title":"Excessive daytime sleepiness and unintended sleep in Parkinson's disease","volume":"6","author":"Rye","year":"2006","journal-title":"Curr Neurol Neurosci Rep."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib149","doi-asserted-by":"crossref","first-page":"137","DOI":"10.11138\/FNeur\/2017.32.3.137","article-title":"Obstructive sleep apnea syndrome in Parkinson's disease and other parkinsonisms","volume":"32","author":"Crosta","year":"2017","journal-title":"Funct Neurol"},{"issue":"12","key":"10.1007\/s13311-020-00938-y_bib150","doi-asserted-by":"crossref","first-page":"e82091","DOI":"10.1371\/journal.pone.0082091","article-title":"Risk of obstructive sleep apnea in Parkinson's disease: a meta-analysis","volume":"8","author":"Zeng","year":"2013","journal-title":"PLoS One."},{"issue":"12","key":"10.1007\/s13311-020-00938-y_bib151","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.sleep.2014.09.014","article-title":"Supine sleep and obstructive sleep apnea syndrome in Parkinson's disease","volume":"16","author":"Cochen De Cock","year":"2015","journal-title":"Sleep Med."},{"issue":"8","key":"10.1007\/s13311-020-00938-y_bib152","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4103\/0366-6999.229888","article-title":"Effect of Rapid Eye Movement Sleep Behavior Disorder on Obstructive Sleep Apnea Severity and Cognition of Parkinson's Disease Patients","volume":"131","author":"Huang","year":"2018","journal-title":"Chin Med J (Engl)."},{"key":"10.1007\/s13311-020-00938-y_bib153","first-page":"849472","article-title":"The Interaction between Obstructive Sleep Apnea and Parkinson's Disease: Possible Mechanisms and Implications for Cognitive Function","volume":"2015","author":"Kaminska","year":"2015","journal-title":"Parkinsons Dis."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib154","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3233\/JPD-150602","article-title":"Observational Study of the Relation between Parkinson's Disease and Sleep Apnea","volume":"5","author":"B\u00e9land","year":"2015","journal-title":"J Parkinsons Dis."},{"key":"10.1007\/s13311-020-00938-y_bib155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.sleep.2016.01.001","article-title":"Obstructive Sleep Apnea and Cognition in Parkinson's disease","volume":"21","author":"Harmell","year":"2016","journal-title":"Sleep Med."},{"issue":"12","key":"10.1007\/s13311-020-00938-y_bib156","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1212\/WNL.0000000000003738","article-title":"Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea","volume":"88","author":"Mery","year":"2017","journal-title":"Neurology."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib157","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5665\/sleep.3332","article-title":"Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea","volume":"37","author":"Neikrug","year":"2014","journal-title":"Sleep."},{"key":"10.1007\/s13311-020-00938-y_bib158","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.sleep.2017.01.009","article-title":"Treating sleep apnea in Parkinson's disease with C-PAP: feasibility concerns and effects on cognition and alertness","volume":"33","author":"Terzaghi","year":"2017","journal-title":"Sleep Med."},{"issue":"8","key":"10.1007\/s13311-020-00938-y_bib159","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jamaneurol.2018.0640","article-title":"A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy","volume":"75","author":"De Pablo-Fern\u00e1ndez","year":"2018","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1007\/s13311-020-00938-y_bib160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40478-018-0596-z","article-title":"Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease","volume":"6","author":"Ortu\u00f1o-Lizar\u00e1n","year":"2018","journal-title":"Acta Neuropathol Commun."},{"issue":"9","key":"10.1007\/s13311-020-00938-y_bib161","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrneurol.2011.107","article-title":"How might physical activity benefit patients with Parkinson disease?","volume":"7","author":"Speelman","year":"2011","journal-title":"Nat Rev Neurol."},{"issue":"4","key":"10.1007\/s13311-020-00938-y_bib162","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","article-title":"Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease","volume":"71","author":"Videnovic","year":"2014","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1007\/s13311-020-00938-y_bib163","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1007\/s13311-020-00938-y_bib164","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/07420520701420717","article-title":"Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study","volume":"24","author":"Willis","year":"2007","journal-title":"Chronobiol Int."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00938-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00938-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00938-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:56:47Z","timestamp":1761807407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923012540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":164,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1878747923012540"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00938-y","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sleep Issues in Parkinson's Disease and Their Management","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00938-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}